Treatment of Migraines
First-line treatments for acute migraine episodes include NSAIDs (ibuprofen or naproxen), acetaminophen, or a combination of NSAID + acetaminophen, with triptans (sumatriptan, rizatriptan, eletriptan) recommended for moderate to severe migraines. 1
Acute Treatment Algorithm
Step 1: Initial Treatment Based on Severity
Mild to Moderate Migraines:
Moderate to Severe Migraines:
Step 2: For Persistent Migraines
- If migraine persists >1 week after initial treatment and oral medications are ineffective, consider parenteral therapy 1
- Add antiemetic when nausea is prominent 1
Step 3: Refractory Migraines
- For patients not responding to NSAIDs or triptans alone, consider combination therapy (triptan + NSAID simultaneously) 5
Important Safety Considerations
Medication Overuse Risk:
Triptan Contraindications:
Preventive Treatment
Consider preventive therapy for patients with ≥2 migraines per month, prolonged/disabling attacks, or reduced quality of life between attacks. 1
First-line Preventive Options:
- Beta-blockers: Propranolol (80-240 mg/day), Timolol (20-30 mg/day) 1
- Antidepressants: Amitriptyline (30-150 mg/day) 1
- Anticonvulsants: Topiramate (100 mg/day), Divalproex sodium (500-1500 mg/day) 1
- CGRP antagonists: Erenumab, fremanezumab, galcanezumab (for inadequate response after second injection) 1
Complementary Approaches:
- Magnesium supplements (400-600mg daily) 1
- Riboflavin supplements (400mg daily) 1
- Coenzyme Q10 supplements 1
Lifestyle Modifications
- Regular sleep schedule
- Consistent meal times
- Adequate hydration
- Regular physical activity
- Stress management techniques
- Identification and avoidance of personal triggers 1
Clinical Pearls
- Acetaminophen is the safest option during pregnancy 1, 5
- Triptans show superior efficacy compared to NSAIDs for moderate-severe attacks, but may be more expensive 6
- NSAIDs work through blocking cyclooxygenase and decreasing prostaglandin synthesis, which are involved in migraine pathophysiology 7
- OTC medications are appropriate first-line for mild-moderate attacks but patients with disability in >50% of attacks or vomiting in >20% of attacks should seek prescription options 8
- The efficacy of rizatriptan is unaffected by patient age, gender, or concomitant use of common migraine prophylactic drugs 3
- Target a 50% reduction in attack frequency for preventive therapy, allowing 6-8 weeks at therapeutic dose to assess effectiveness 1